Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Baier Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Baier Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Baier Biotechnology
Manufacturer of biotechnology products aims to advance innovative life science research and medical applications. The company's offerings feature cell biology reagents, molecular biology tools, diagnostic solutions, and customized biotechnology services, supported by strong R&D capabilities, advanced laboratory platforms, and a professional scientific team, enabling breakthroughs in scientific research, healthcare development, and industrial biotechnology.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2018
- Ownership
- Privately Held (backing)
Baier Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Baier Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Baier Biotechnology in its N-PORT filings yet. We sweep new filings monthly.